Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Sum of short-term and long-term debt obligations
3Y CAGR
+12.1%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.25M | +31.8% |
| 2024 | $6.26M | -96.8% |
| 2023 | $193.19M | +3203.0% |
| 2022 | $5.85M | +19.1% |
| 2021 | $4.91M | - |